Results 201 to 210 of about 2,510,704 (333)
Delta-wave automatic mapping of the manifest accessory pathway. [PDF]
Iacopino S+17 more
europepmc +1 more source
Opening a Window into Accessory Pathway Mapping in Children with Wolff-Parkinson-White Syndrome? [PDF]
Regan W, Harris K, Rosenthal E.
europepmc +1 more source
Colonic Submucosa Targeted Delivery of Probiotic and Rhein for Ulcerative Colitis Treatment
A novel orally drug‐probiotic co‐delivery system designated as Rh‐YBS for UC treatment, which highlights three innovations: (i) YPs involves colonic submucosa delivery via M cells; (ii) Rh (drug) promotes the colonization and growth of BS (probiotic) in the colon.
Lingqiang Li+21 more
wiley +1 more source
Brugada syndrome in a patient with accessory pathway [PDF]
Andrés Bodegas
openalex +1 more source
XLP mitigated CPT11 mucositis by suppressing GUS‐expressing microbes, notably L. reuteri, and diminishing bacterial GUS activity, consequently reducing SN38 accumulation to protect the intestinal epithelium. This preservation of the mucosal stem cell niche enabled rapid regeneration of secretory lineages such as mucin‐producing goblet cells, which ...
Bei Yue+15 more
wiley +1 more source
Cryoablation for Septal Accessory Pathways: [PDF]
Paul Stobie, Martin S. Green
openalex +1 more source
Based on IP‐MS analysis, BAG2 is confirmed to be essential for ubiquitination and protein homeostasis regulation of STING in cervical cancer. BAG2 inhibits the ubiquitination and degradation of STING by forming a complex with STUB1, thereby activating the type I IFN signaling pathway and inhibiting the development of cervical cancer.
Shijie Yao+6 more
wiley +1 more source